Where are we going with SSRIs?
- 8 July 1999
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 9, S101-S106
- https://doi.org/10.1016/s0924-977x(99)00028-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Paroxetine in social phobia/social anxiety disorderThe British Journal of Psychiatry, 1999
- Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorderEuropean Neuropsychopharmacology, 1998
- Effect of Pindolol on Onset of Action of Paroxetine in the Treatment of Major Depression: Intermediate Analysis of a Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 1998
- Combining pindolol and paroxetine in an animal model of chronic antidepressant action—can early onset of action be detected?European Journal of Pharmacology, 1998
- P.1.138 Depression in breast cancer patients — comparison of paroxetine and amitriptylineEuropean Neuropsychopharmacology, 1997
- Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trialAmerican Journal of Psychiatry, 1997
- Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorderInternational Clinical Psychopharmacology, 1996
- Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major DepressionJournal of Clinical Psychopharmacology, 1995
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990